KaloBios Pharmaceuticals has been notified by Nasdaq that it will delist the stock by Dec. 30, due to the criminal indictment and arrest of Martin Shkreli, and the firm's former outside counsel, Evan Greebel. The company - which hasn't traded since last Thursday - hasn't decided whether it will appeal the decision. Deeper troubles? KaloBios (NASDAQ:KBIO) also hasn't filed its 10-Q for the period ended Sept. 30.
The company has failed to comply with NASDAQ's Listing Rule 5101. KBIO also disclosed in the filing that its independent registered public account firm, Marcum LLP has resigned. KBIO noted that the resignation was not due to any reason related to its reporting or accounting operations, policies or procedures. Christopher Thorn, the company's interim CFO has also resigned.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
Que tengáis una feliz navidad y unas felices fiestas farmadictos!!!
Agradecer además a los que subis información constante para ayudar a tomar decisiones y q estemos actualizados.
Aunque tan solo llevo 2 o 3 meses invirtiendo en farmas ya me considero un farmadicto, de momento para bien! Lo primero que hago cuando me levanto es mirar este hilo :)